Operating income increased 14.7%
Operating income changed +14.7% from the comparable as-filed period.
$62.3M→$71.5M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income decreased 23.6%
Net income changed -23.6% from the comparable as-filed period.
$48.0M→$36.7M2 prior comparisons
Receivables / revenue moved 733 bp higher
Receivables / revenue changed +733 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
61.19%→68.52%2 prior comparisons
Operating margin moved 17 bp lower
Operating margin changed -17 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
13.06%→12.89%2 prior comparisons
Current liabilities increased 15.8%
Current liabilities changed +15.8% from the comparable as-filed period.
$1.2B→$1.4B3 prior comparisons
Gross profit increased 15.0%
Gross profit changed +15.0% from the comparable as-filed period.
$392.1M→$451.1M2 prior comparisons
Operating cash flow / net income increased 48.6%
Operating cash flow / net income changed +48.6% from the comparable as-filed period.
5.62→8.362 prior comparisons
Working capital / assets moved 796 bp lower
Working capital / assets changed -796 basis points from the comparable as-filed period.
15.18%→7.21%3 prior comparisons
Cost of revenue increased 21.4%
Cost of revenue changed +21.4% from the comparable as-filed period.
$85.2M→$103.5M2 prior comparisons
Current assets decreased 6.9%
Current assets changed -6.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$1.9B→$1.7B3 prior comparisons
Capital expenditure decreased 57.9%
Capital expenditure changed -57.9% from the comparable as-filed period.
$7.5M→$3.2M2 prior comparisons
Gross margin moved 80 bp lower
Gross margin changed -80 basis points from the comparable as-filed period.
82.15%→81.34%2 prior comparisons
SBC / revenue moved 179 bp lower
SBC / revenue changed -179 basis points from the comparable as-filed period.
15.06%→13.27%2 prior comparisons
R&D / revenue moved 186 bp higher
R&D / revenue changed +186 basis points from the comparable as-filed period.
22.66%→24.52%2 prior comparisons
Stockholders' equity decreased 9.2%
Stockholders' equity changed -9.2% from the comparable as-filed period.
$2.7B→$2.5B2 prior comparisons
Capex / revenue moved 100 bp lower
Capex / revenue changed -100 basis points from the comparable as-filed period.
1.57%→0.57%2 prior comparisons
Current ratio decreased 19.6%
Current ratio changed -19.6% from the comparable as-filed period.
1.5→1.213 prior comparisons
Operating cash-flow margin moved 127 bp lower
Operating cash-flow margin changed -127 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
56.50%→55.22%2 prior comparisons
Total assets increased 0.7%
Total assets changed +0.7% from the comparable as-filed period.
$4.1B→$4.1B3 prior comparisons
Free-cash-flow margin moved 28 bp lower
Free-cash-flow margin changed -28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
54.93%→54.66%2 prior comparisons
Stock-based compensation increased 2.3%
Stock-based compensation changed +2.3% from the comparable as-filed period.
$71.9M→$73.6M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.